American Heart Journal
Volume 152, Issue 4 , Pages 676-683 , October 2006

Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes

  • Raymond T. Yan, MD, MASc

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Andrew T. Yan, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Mary Tan, BSc

      Affiliations

    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Darren K. McGuire, MD

      Affiliations

    • Donald W. Reynolds Cardiovascular Clinical Research Centre, Division of Cardiology at the University of Texas Southwestern Medical Centre, Dallas, TX
    • ,
  • Lawrence Leiter, MD

      Affiliations

    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Division of Endocrinology, St. Michael's Hospital, University of Toronto, Toronto, Canada
    • ,
  • David H. Fitchett, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Claude Lauzon, MD

      Affiliations

    • CHRA, Division of Internal Medicine, Thetford Mines, Quebec, Canada
    • ,
  • Kevin Lai, MD

      Affiliations

    • Nanaimo Regional General Hospital, Nanaimo, British Columbia, Canada
    • ,
  • Chi-Ming Chow, MD, MSc

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Anatoly Langer, MD, MSc

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Shaun G. Goodman, MD, MSc

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Dr Shaun G. Goodman, MD, Division of Cardiology, St Michael's Hospital, 30 Bond Street, Room 6-034 Queen, Toronto, Ontario, Canada M5B 1W8.
    • ,
  • for the Canadian Acute Coronary Syndrome Registry Investigators

Received 21 October 2005 ,Accepted 3 April 2006.

References 

  1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;387:356–359
  2. The Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) Investigators. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction . J Am Coll Cardiol. 1997;30:171–179
  3. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non–Q-wave myocardial infarction. Results of the OASIS Registry. Circulation. 2000;102:1014–1019
  4. Norhammar A, Malmberg K, Ryden L, et al. Under utilization of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J. 2003;24:838–844
  5. Franklin K, Goldberg RJ, Spencer F, et al. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med. 2004;164:1457–1463
  6. Barron HV, Bowlby LJ, Breen T, et al. Use of reperfusion therapy for acute myocardial infarction in the United States. Data from the National Registry of Myocardial Infarction 2. Circulation. 1998;97:1150–1156
  7. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495–2499
  8. Fergus TS, Fazel R, Fang J, et al. Presentation, management, and outcomes of diabetic patients compared to non-diabetic patients admitted for acute coronary syndromes. Heart. 2004;90:1051–1052
  9. Yan AT, Tan M, Fitchett D, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol. 2004;94:25–29
  10. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome. JAMA. 2004;291:2727–2733
  11. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
  12. Antman EM, Anbe DT, Armstong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. Circulation. 2004;110:1–48
  13. Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaprin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000;36:1812–1817
  14. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 1999;340:1623–1629
  15. Vinik AI, Erbas T, Park TS, et al. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24:1476–1485
  16. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. Epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–2581
  17. Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non–ST-segment-elevation acute coronary syndromes. Circulation. 2001;104:2767–2771
  18. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low–molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 1997;337:447–452
  19. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
  20. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet. 1998;351:1755–1762
  21. Second International Study on Infarct Survival Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:530–535
  22. Mahaffey KW, Granger CB, Toth CA, et al. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in GUSTO-I trial. J Am Coll Cardiol. 1997;30:1606–1610
  23. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–322
  24. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation. 2002;106:1883–1890
  25. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887
  26. Fragmin and Fast Revascularization during Instability in Coronary Artery Disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Lancet. 1999;354:708–715
  27. Mehran R, Dangas GD, Kobayashi Y, et al. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol. 2004;43:1348–1354
  28. Chen J, Marciniak TA, Radford MJ, et al. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol. 1999;34:1388–1394
  29. American Diabetes Association . Standards of medical care in diabetes. Diabetes Care. 2005;28(Supp 1):S4–S36

 This research was sponsored by the Canadian Heart Research Centre and Key Pharmaceuticals, Division of Schering Canada Inc. Drs Fitchett, Lauzon, Lai, Langer, and Goodman have received research grant support and speaker/consultant honoraria from Schering Canada Inc. Dr McGuire has received research grant support and speaker/consultant honoraria from Pfizer, GlaxoSmithKline, Wyeth, Sanofi-Aventis, Guilford, and Takeda. Dr Andrew Yan is supported by the Canadian Institutes of Health Research Fellowship Award, the Canadian Heart Research Centre Fellowship, and the Detweiler Travelling Fellowship.

PII: S0002-8703(06)00322-X

doi: 10.1016/j.ahj.2006.04.002

American Heart Journal
Volume 152, Issue 4 , Pages 676-683 , October 2006

Article Tools